Inventor · disambiguated record
Chandeshwari Chilampalli
Also filed as: CHILAMPALLI CHANDESHWARI · CHILAMPALLI CHANDESHWARI S · CHILAMPALLI CHANDESHWARI SHIVANI
22 granted patents·3 pending applications·129 citations·filing 2014–2023
94Inventor score
Top patents by PatentIndex Score
25 records- 0197US11628139B2Liquid naloxone sprayHIKMA PHARMACEUTICALS USA INC·Filed 2021·Granted Apr 18, 2023·7 cites·12 claims
- 0296US11617713B2Liquid naloxone sprayHIKMA PHARMACEUTICALS USA INC·Filed 2021·Granted Apr 4, 2023·4 cites·18 claims
- 0396US11135155B2Liquid naloxone sprayHIKMA PHARMACEUTICALS USA INC·Filed 2018·Granted Oct 5, 2021·8 cites·19 claims
- 0496US10441538B2Liquid naloxone sprayINSYS DEV CO INC·Filed 2018·Granted Oct 15, 2019·16 cites·10 claims
- 0596US10039710B2Epinephrine spray formulationsINSYS DEV CO INC·Filed 2017·Granted Aug 7, 2018·27 cites·27 claims
- 0695US11975096B2Liquid naloxone sprayHIKMA PHARMACEUTICALS USA INC·Filed 2021·Granted May 7, 2024·2 cites·19 claims
- 0795US10973814B2Liquid naloxone sprayHIKMA PHARMACEUTICALS USA INC·Filed 2019·Granted Apr 13, 2021·10 cites·12 claims
- 0894US9216175B2Sublingual buprenorphine sprayINSYS PHARMA INC·Filed 2014·Granted Dec 22, 2015·34 cites·14 claims
- 0992US9918981B2Liquid buprenorphine formulationsINSYS DEV CO INC·Filed 2016·Granted Mar 20, 2018·6 cites·20 claims
- 1092US9839611B2Sublingual buprenorphine sprayINSYS DEV CO INC·Filed 2015·Granted Dec 12, 2017·7 cites·18 claims
- 1191US11077075B2Methods of stabilizing epinephrineINSYS DEV CO INC·Filed 2019·Granted Aug 3, 2021·5 cites·16 claims
- 1287US11744811B2Methods of stabilizing epinephrineHIKMA PHARMACEUTICALS USA INC·Filed 2021·Granted Sep 5, 2023·1 cites·19 claims
- 1384US12414915B2Liquid naloxone sprayHIKMA PHARMACEUTICALS USA INC·Filed 2023·Granted Sep 16, 2025·0 cites·1 claims
- 1484US11571384B2Epinephrine spray formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2018·Granted Feb 7, 2023·2 cites·24 claims
- 1577US2023390218A1Epinephrine spray formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2023·Application pending·0 cites
- 1670US11771663B2Epinephrine spray formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2021·Granted Oct 3, 2023·0 cites·16 claims
- 1770US10966925B2Epinephrine spray formulationsINSYS DEV CO INC·Filed 2019·Granted Apr 6, 2021·0 cites·10 claims
- 1868US11517525B2Epinephrine spray formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2018·Granted Dec 6, 2022·0 cites·16 claims
- 1968US10617637B2Epinephrine spray formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2018·Granted Apr 14, 2020·0 cites·14 claims
- 2064US10973781B2Epinephrine spray formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2019·Granted Apr 13, 2021·0 cites·4 claims
- 2158US9566233B2Ondansetron sublingual spray formulationINSYS PHARMA INC·Filed 2014·Granted Feb 14, 2017·0 cites·14 claims
- 2255US10172833B2Sublingual ondansetron sprayINSYS DEV CO INC·Filed 2016·Granted Jan 8, 2019·0 cites·16 claims
- 2348US9867818B2Sublingual buprenorphine sprayINSYS DEV CO INC·Filed 2016·Granted Jan 16, 2018·0 cites·11 claims
- 2448US2018153795A1Liquid buprenorphine formulationsINSYS DEV CO INC·Filed 2018·Application pending·0 cites
- 2545US2017105970A1Ondansetron sublingual spray formulationINSYS DEV CO INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →